Safety and Immune Response of Novartis of MenACWY Conjugate Vaccine When Given to Healthy Children

Inclusion Criteria: * healthy 2-10 years of age children, inclusive and for whom, after the nature of the study has been explained, the parent or legal guardian has provided written informed consent * who are available for all visits and telephone calls scheduled for the study * who are up-to-date with age-appropriate routine childhood vaccinations Exclusion Criteria: * whose parent or legal guardian is unwilling or unable to give written informed consent * who had a previous or suspected disease caused by N. meningitidis; * who have previously been immunized with a meningococcal vaccine or vaccine containing meningococcal antigen(s) * who have received any investigational agents or vaccines within 90 days prior to enrollment * who have any serious acute, chronic or progressive disease * who have epilepsy or any progressive neurological disease or history of Guillain Barré Syndrome * who have a history of anaphylaxis, serious vaccine reactions * who have a known or suspected impairment/alteration of immune function, either congenital or acquired or resulting from * who are known to have a bleeding diathesis, or any condition that may be associated with a prolonged bleeding time * who have Down's syndrome or other known cytogenic disorders